Ryan David  Lake net worth and biography

Ryan Lake Biography and Net Worth

CFO of Recro Pharma
Ryan David Lake serves as Chief Financial Officer of the Company. He had previously served as our Senior Vice President of Finance and Chief Accounting Officer since June 2017. Mr. Lake has also served as the Chief Financial Officer of Baudax Bio since the Separation in November 2019. Mr. Lake has over 20 years of senior financial and life sciences leadership experience. Prior to joining us, Mr. Lake served as Chief Financial Officer and Vice President of Finance of Aspire Bariatrics, Inc., a privately-held, commercial-stage, medical device company from July 2015 to May 2017. From 2012 to 2015, Mr. Lake held executive management and senior finance positions, including Director of the Natural Materials Division, Controller and Senior Director of Finance, at DSM Biomedical (successor to Kensey Nash Corporation after its acquisition in 2012), a division of Royal DSM (listed on Euronext Amsterdam), a global science-based company active in health, nutrition and materials. From 2002 to 2012, Mr. Lake held various senior financial positions of increasing responsibility, most notably Senior Director of Finance and Interim Chief Financial Officer, with Kensey Nash Corporation, a medical device company. Earlier in his career, Mr. Lake worked at Deloitte & Touche, LLP. Mr. Lake has a B.S. degree in Accounting from West Chester University of Pennsylvania and is a certified public accountant and Chartered Global Management Accountant.

How do I contact Ryan David Lake?

The corporate mailing address for Mr. Lake and other Recro Pharma executives is 490 LAPP ROAD, MALVERN PA, 19355. Recro Pharma can also be reached via phone at (770) 534-8239 and via email at [email protected]. Learn More on Ryan David Lake's contact information.

Has Ryan David Lake been buying or selling shares of Recro Pharma?

Ryan David Lake has not been actively trading shares of Recro Pharma during the past quarter. Most recently, on Friday, November 12th, Ryan David Lake bought 1,212 shares of Recro Pharma stock. The stock was acquired at an average cost of $1.65 per share, with a total value of $1,999.80. Learn More on Ryan David Lake's trading history.

Who are Recro Pharma's active insiders?

Recro Pharma's insider roster includes J. Enloe, Jr. (CEO), Ryan Lake (CFO), and James Miller (Director). Learn More on Recro Pharma's active insiders.

Ryan David Lake Insider Trading History at Recro Pharma

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/12/2021Buy1,212$1.65$1,999.80View SEC Filing Icon  
See Full Table

Ryan David Lake Buying and Selling Activity at Recro Pharma

This chart shows Ryan David Lake's buying and selling at Recro Pharma by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Recro Pharma Company Overview

Recro Pharma logo
Recro Pharma, Inc. is a pharmaceutical company, which engages in the contract development and manufacturing organization (CDMO). The firm offers integrated solutions for formulation, analytical services, regulatory support, manufacturing and packaging of both commercial and development stage oral solid dose drug products. The company was founded by Geraldine A. Henwood and Thomas F. Henwood on November 15, 2007 and is headquartered in Exton, PA.
Read More

Today's Range

Now: N/A

50 Day Range

MA: $1.73
Low: $1.47
High: $2.11

2 Week Range

Now: N/A

Volume

141,800 shs

Average Volume

126,298 shs

Market Capitalization

$117.93 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.08